Literature DB >> 22009071

Predicted 25-hydroxyvitamin D score and change in fasting plasma glucose in the Framingham offspring study.

E Liu1, N M McKeown, A G Pittas, J B Meigs, C D Economos, S L Booth, P F Jacques.   

Abstract

Data on the association between vitamin D status and actual change in glycemic measures are limited. We examined the prospective association between a predicted 25-hydroxyvitamin D (25(OH)D) score and change in fasting plasma glucose concentration over a mean follow-up of 7 years, in 2571 men and women (mean age 54 years) without diabetes in the Framingham Offspring Study cohort. After adjustment for age, sex, body mass index and fasting plasma glucose at baseline, higher predicted 25(OH)D score at baseline was associated with a smaller 7-year increase in fasting plasma glucose concentrations (0.23 mmol/l versus 0.35 mmol/l for highest versus lowest tertile of 25(OH)D score, respectively, P-trend=0.002). Vitamin D status may be an important determinant for change in fasting plasma glucose concentration among middle-aged and older adults without diabetes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22009071      PMCID: PMC3796766          DOI: 10.1038/ejcn.2011.181

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  17 in total

Review 1.  Minireview: vitamin D receptor: new assignments for an already busy receptor.

Authors:  Anthony W Norman
Journal:  Endocrinology       Date:  2006-08-31       Impact factor: 4.736

2.  Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults.

Authors:  Earl S Ford; Umed A Ajani; Lisa C McGuire; Simin Liu
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

3.  The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults.

Authors:  Anastassios G Pittas; Susan S Harris; Paul C Stark; Bess Dawson-Hughes
Journal:  Diabetes Care       Date:  2007-02-02       Impact factor: 19.112

4.  Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study.

Authors:  Enju Liu; James B Meigs; Anastassios G Pittas; Christina D Economos; Nicola M McKeown; Sarah L Booth; Paul F Jacques
Journal:  Am J Clin Nutr       Date:  2010-04-14       Impact factor: 7.045

5.  Vitamin D and calcium intake in relation to type 2 diabetes in women.

Authors:  Anastassios G Pittas; Bess Dawson-Hughes; Tricia Li; Rob M Van Dam; Walter C Willett; Joann E Manson; Frank B Hu
Journal:  Diabetes Care       Date:  2006-03       Impact factor: 19.112

Review 6.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis.

Authors:  Anastassios G Pittas; Joseph Lau; Frank B Hu; Bess Dawson-Hughes
Journal:  J Clin Endocrinol Metab       Date:  2007-03-27       Impact factor: 5.958

7.  Prospective study of predictors of vitamin D status and cancer incidence and mortality in men.

Authors:  Edward Giovannucci; Yan Liu; Eric B Rimm; Bruce W Hollis; Charles S Fuchs; Meir J Stampfer; Walter C Willett
Journal:  J Natl Cancer Inst       Date:  2006-04-05       Impact factor: 13.506

8.  Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey.

Authors:  Robert Scragg; MaryFran Sowers; Colin Bell
Journal:  Diabetes Care       Date:  2004-12       Impact factor: 19.112

9.  Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells.

Authors:  B Maestro; J Campión; N Dávila; C Calle
Journal:  Endocr J       Date:  2000-08       Impact factor: 2.349

10.  Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women.

Authors:  Allan G Need; Peter D O'Loughlin; Michael Horowitz; B E Christopher Nordin
Journal:  Clin Endocrinol (Oxf)       Date:  2005-06       Impact factor: 3.478

View more
  7 in total

1.  Association of vitamin D and vitamin D receptor gene polymorphisms with chronic inflammation, insulin resistance and metabolic syndrome components in type 2 diabetic Egyptian patients.

Authors:  Amal M H Mackawy; Mohammed E H Badawi
Journal:  Meta Gene       Date:  2014-08-07

2.  Relationship between Vitamin D Receptor gene polymorphisms and the components of metabolic syndrome.

Authors:  Natielen Jacques Schuch; Vivian Cristina Garcia; Sandra Roberta Gouvea Ferreira Vívolo; Lígia Araújo Martini
Journal:  Nutr J       Date:  2013-07-15       Impact factor: 3.271

Review 3.  Is Hypovitaminosis D Related to Incidence of Type 2 Diabetes and High Fasting Glucose Level in Healthy Subjects: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Shamaila Rafiq; Per Bendix Jeppesen
Journal:  Nutrients       Date:  2018-01-10       Impact factor: 5.717

4.  Efficacy of vitamin D supplementation on glycemic control in type 2 diabetes patients: A meta-analysis of interventional studies.

Authors:  Zhiwei Hu; Jin'an Chen; Xinjuan Sun; Lei Wang; Aiping Wang
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

5.  Decreased serum concentrations of 25-hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes.

Authors:  Anat Tsur; Becca S Feldman; Ilan Feldhammer; Moshe B Hoshen; Gil Leibowitz; Ran D Balicer
Journal:  Diabetes Care       Date:  2013-02-07       Impact factor: 19.112

6.  Association of vitamin D receptor gene polymorphisms with metabolic syndrome: a case-control design of population-based cross-sectional study in North China.

Authors:  Yi Zhao; Sha Liao; Jun He; Yanan Jin; Hailong Fu; Xiaoying Chen; Xuemin Fan; Hongxia Xu; Xiuying Liu; Jing Jin; Yuhong Zhang
Journal:  Lipids Health Dis       Date:  2014-08-09       Impact factor: 3.876

7.  Consensus statement from 2nd International Conference on Controversies in Vitamin D.

Authors:  A Giustina; R A Adler; N Binkley; J Bollerslev; R Bouillon; B Dawson-Hughes; P R Ebeling; D Feldman; A M Formenti; M Lazaretti-Castro; C Marcocci; R Rizzoli; C T Sempos; J P Bilezikian
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.